Page 111 - TD-4-2
P. 111

Tumor Discovery                                                       DLBCL in the splenic hilar lymph node



            and stage I/II DLCBL, 3,4,6,8,10,17  our case was managed   References
            postoperatively with three courses of the PvRCHP regimen   1.   Coupland SE, Du MQ, Ferry JA, et al. The fifth edition of
            due to concerns regarding potential poor prognosis.   the WHO classification of mature B-cell neoplasms: Open
                                                                  questions for research. J Pathol. 2024;262(3):255-270.
            4. Conclusion
                                                                  doi: 10.1002/path.6246
            In this case, after surgical resection and subsequent gross
            and microscopic examinations, it was determined that the   2.   Shimizu-Kohno K, Kimura Y, Kiyasu J,  et al. Malignant
                                                                  lymphoma  of  the  spleen  in  Japan:  A  clinicopathological
            mass originated from the splenic hilar lymph node, despite   analysis of 115 cases. Pathol Int. 2012;62:577-582.
            pre-operative imaging studies (CT, PET/CT) suggesting
            an intrasplenic tumor. Thus, even when imaging studies      doi: 10.1111/j.1440-1827.2012.02844.x
            indicate an intrasplenic mass, caution must be exercised   3.   Shimono J, Miyoshi H, Kiyasu J, et al. Clinicopathological
            regarding the possibility of lymphoma located outside the   analysis of primary splenic diffuse large B-cell lymphoma.
            spleen, potentially within the splenic hilar lymph node.  Br J Haematol. 2017;178:719-727.
                                                                  doi: 10.1111/bjh.14736
            Acknowledgments
                                                               4.   Rajendran T, Kini JR, Abna A, Prasad K. Clinical benefit
            This study was conducted with the support of the medical   of R-CHOP without splenectomy in stage I primary
            staff at the Uji Tokushukai Medical Center. The authors   splenic diffuse large B-cell lymphoma.  BMJ Case
            thank Professor Kouichi Ohshima, Professor Junji      Rep. 2022;15(1):e246610.
            Suzumiya, and Professor Motoko Yamaguchi for their      doi: 10.1136/bcr-2021-246610
            helpful comments on this case.
                                                               5.   Wadsworth PA, Miranda RN, Bhakta P,  et al. Primary
            Funding                                               splenic diffuse large B-cell lymphoma presenting as a splenic
                                                                  abscess. EJHaem. 2023;4:226-231.
            None.                                                 doi: 10.1002/jha2.642
            Conflict of interest                               6.   Meng M, Riera CA, Mosquera J, Parikh HR, Singh A. Atypical
                                                                  diffuse large B-cell lymphoma, primary splenic lymphoma
            The authors declare no conflicts of interest.         variant; A case report. Int J Surg Case Rep. 2023;111:108861.
            Author contributions                                  doi: 10.1016/j.ijscr.2023.108861
                                                               7.   Yonghao Q, Yongyang W, Siqing Y, Lihua C, Shuju T.
            Conceptualization: Naoyuki Anzai, Yutaka Shimazu,     Comparison of survival outcomes of different treatment
               Shinsaku Imashuku                                  modalities for patients with primary splenic diffuse large B
            Investigation:  Ayaka Fukui, Naoki Nakajima, Shinsaku   cell lymphoma. Ann Hematol. 2023;102(7):1857-1865.
               Imashuku
            Writing – original draft: Naoyuki Anzai, Yutaka Shimazu,      doi: 10.1007/s00277-023-05171-z
               Shinsaku Imashuku                               8.   Pirzada S, Hasnain A, Mankani AA, Zahid I. Primary splenic
            Writing – review & editing: All authors               diffuse large b-cell lymphoma: An atypical presentation.
                                                                  Cureus. 2023;15(6):e40793.
            Ethics approval and consent to participate            doi: 10.7759/cureus.40793
            The work was carried out following the Declaration of   9.   Neves NM, Lopes AP, Coelho SC, Raimundo A, Mafra MM,
            Helsinki as revised in 2013. This case report was approved   Horta AB. Primary splenic diffuse large B-cell lymphoma:
            by the institutional review board (Uji-Tokushukai Medical   A case report. Eur J Case Rep Intern Med. 2023;10(7):003932.
            Center Ethics Committee; IRB approval No.  2024-45).      doi: 10.12890/2023_003932
            The patient provided written consent to participate in this   10.  Seijari  MN,  Kaspo  S,  Alshurafa  A,  Elfaieg  A,  Sarah  A
            study.                                                Elkourashy SA. Primary splenic diffuse large B-cell
                                                                  lymphoma: A  case report and literature review of a rare
            Consent for publication                               condition. Case Rep Oncol. 2024;17(1):447-453.
            Written informed consent was obtained from the patient.     doi: 10.1159/000537780

            Availability of data                               11.  Justo I, Jiménez-Romero C, Suárez A, et al. Case study:
                                                                  Splenic cyst deroofing complicated with B lymphoma. World
            Data are available upon request from the authors.     J Surg Oncol. 2024;22:231.


            Volume 4 Issue 2 (2025)                        103                                doi: 10.36922/td.6742
   106   107   108   109   110   111   112   113   114   115   116